Consistently, mouse fibroblasts isolated from syntenin knockout mice show lesser amounts of HSPGs, which correlates with reduced uptake of exosomes, suggesting that syntenin may be a nonnegligible target for inhibiting tumor development [79]. The gene discussed is SDCBP; the disease is neoplasm.